Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.
about
Update on Barriers to Pharmacotherapy for Opioid Use Disorders.Treatment entry among individuals on a waiting list for methadone maintenance.Does the impact of managed care on substance abuse treatment services vary by provider profit status?Effect of quality chronic disease management for alcohol and drug dependence on addiction outcomesBuprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?Patients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care.Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.Wait times for publicly funded addiction and problem gambling treatment agencies in Ontario, Canada.Pharmacological enhancement of naltrexone treatment for opioid dependence: a reviewCultural competence in outpatient substance abuse treatment: measurement and relationship to wait time and retention.Patterns in admission delays to outpatient methadone treatment in the United StatesDropout from interim methadone and subsequent comprehensive methadone maintenanceProgram Capacity to Eliminate Outcome Disparities in Addiction Health Services.Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.Substance abuse and batterer programmes in California, USA: factors associated with treatment outcomesInterim treatment: Bridging delays to opioid treatment access.Challenges in motivating treatment enrollment in community syringe exchange participants.Integration of Substance Abuse Treatment Organizations into Accountable Care Organizations: Results from a National Survey.Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care ReformIndividual and system influences on waiting time for substance abuse treatment.Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.Naltrexone extended-release injection: an option for the management of opioid abuse.The science and practice of medication-assisted treatments for opioid dependence.A primary care/multidisciplinary harm reduction clinic including opiate bridging.Deaths and severe adverse events associated with anesthesia-assisted rapid opioid detoxification--New York City, 2012.Client and program characteristics associated with wait time to substance abuse treatment entry.Predictors of 16-year mortality among individuals initiating help-seeking for an alcoholic use disorder.Internet-Delivered Dialectical Behavioral Therapy Skills Training for Suicidal and Heavy Episodic Drinkers: Protocol and Preliminary Results of a Randomized Controlled Trial.Health benefits of legal services for criminalized populations: the case of people who use drugs, sex workers and sexual and gender minorities.Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement.
P2860
Q30234408-EAAC2AAA-273E-47C9-959D-0B82FEF4FD3BQ34046596-FE7170BF-CC63-4EBB-9503-88BD60CF8836Q34337758-EA4E3D3F-B56E-4308-964E-A64E481AD72CQ34354970-5136C171-C1D6-49BE-97EB-6BE13AA4A08EQ34403692-EDECA905-88DA-4A41-8F25-33D315E134EBQ34408522-2F3D75C0-4678-45DF-864C-56E84358FDF3Q34724823-C3C3DB95-5682-4547-9A36-7C3BCD7AF5C2Q35046914-A850DD2B-EBEB-4015-85A3-38A664E90B01Q35084340-06AA8D0F-DFD5-4462-99C1-BFDF6FB42026Q35293033-6025EDD1-4D52-419A-A076-CFC504CEDEA6Q35490594-89B1E1F2-DF88-4347-BE96-05534A149E2AQ35491285-35E1A344-0A0D-436F-82F9-571C2C2BFBC1Q35674971-D70F325E-807C-4766-99CB-C453FCC7581CQ36021346-0FF09135-BCE9-42F7-A715-C7652F54E805Q36069067-16E3219A-D5B6-4676-8396-CAF9624ABA19Q36117597-C38F32D1-418A-45FC-A6D0-F609478CF15EQ36272795-766FFE61-BFAD-4705-A623-B2424ABE7FD5Q36440685-9AE2B51A-85FB-4117-B2A0-578AB909A219Q36446470-D818E4BB-76E4-4BF4-B344-29F82BBD347FQ36498680-B938F91D-B219-4E9B-B3D5-926C4C10E541Q36676847-05767C16-B283-4C4C-9DA9-9E31EA167515Q37355293-8C0F6EFC-2A27-4F1B-BAF3-5503205DB687Q39223925-3DBC666B-9023-4293-8B75-AC916CCC9C49Q39858715-075775D8-AF33-439A-A059-67269C8CDCC1Q44341309-1ECDBC12-AF1B-4DF8-8B99-D34F5F8BBE66Q46200890-770F3E26-8784-4219-833D-1D68DAB32B9EQ46226783-788354C5-710D-4EAE-B7B9-D458066DAD1BQ47144090-BE0F273F-953E-404B-B44F-F0F0064C9316Q51827472-F6CFE681-E2BE-4032-A068-C5CE426E851FQ51909421-1A8E750E-67B7-41B4-ABFA-DF830E597B7F
P2860
Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Accessibility of addiction tre ...... abuse treatment organizations.
@ast
Accessibility of addiction tre ...... abuse treatment organizations.
@en
Accessibility of addiction tre ...... abuse treatment organizations.
@nl
type
label
Accessibility of addiction tre ...... abuse treatment organizations.
@ast
Accessibility of addiction tre ...... abuse treatment organizations.
@en
Accessibility of addiction tre ...... abuse treatment organizations.
@nl
prefLabel
Accessibility of addiction tre ...... abuse treatment organizations.
@ast
Accessibility of addiction tre ...... abuse treatment organizations.
@en
Accessibility of addiction tre ...... abuse treatment organizations.
@nl
P2093
P2860
P356
P1476
Accessibility of addiction tre ...... abuse treatment organizations.
@en
P2093
Michael D Stein
Peter D Friedmann
Stephenie C Lemon
Thomas A D'Aunno
P2860
P304
P356
10.1111/1475-6773.00151
P577
2003-06-01T00:00:00Z